New Delhi, February 13 Fortis Healthcare announced on Friday a 22 per cent year-on-year decline in consolidated profit after tax to Rs 197 crore for the quarter ended December 2025.
The company reported a profit after tax (PAT) of Rs 254 crore in the previous year.
Revenue increased to Rs 2,265 crore, compared to Rs 1,928 crore in the October-December quarter of the previous fiscal, Fortis Healthcare said in a statement.
The PAT for the third quarter includes an exceptional loss of Rs 55.2 crore, which is due to the one-time impact of new labor codes, offset by a reversal of impairment in an associate company of Rs 9.4 crore, resulting in a net impact of Rs 45.9 crore, it stated.
"We have witnessed healthy growth in our hospitals business, particularly in key specialties like renal sciences and orthopedics, which grew by 27 per cent and 20 per cent, respectively, compared to the previous period," said Ashutosh Raghuvanshi, MD and CEO of Fortis Healthcare.
The company's acquisition in Bengaluru allows it to strengthen its presence in this market, with approximately 900 beds across seven facilities, and the potential to expand to over 1,500 beds in the future, he added.
"We continue to progress on our brownfield expansion plans and are evaluating further inorganic opportunities in our existing clusters," Raghuvanshi said.
The sustained recovery in both revenue and EBITDA margin for the diagnostics business is encouraging, and the company expects this to progressively improve, he said.
Shares of the company closed 1.22 per cent lower at Rs 916.90 apiece on the BSE on Friday.
